Intellia Therapeutics Conference Call to Address CRISPR/Cas9 U.S. Patent Interference Proceedings

Thursday, February 16, 2017 8:00 a.m. ET

Webcast Presentation – listen here.

Media Contact:

Jennifer Mound Smoter
Chief External Affairs & Communications Officer
(857) 706-1071
jenn.smoter@intelliatx.com

Investor Contacts:

John Graziano
Trout Group
+1 646-378-2942
jgraziano@troutgroup.com

Chad Rubin
Trout Group
+1 646-378-2947
crubin@troutgroup.com

Share this: